FDA Did Not Approve GSK's Advair 500/50 - eMaxHealth.com

FDA Did Not Approve GSK's Advair 500/50eMaxHealth.com, NC - Aug 10, 2007FDA has issued a not approvable letter for GlaxoSmithKline's supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate …

Read full story

Comments

GSK says FDA declines to approve higher dose Advair - Reuters.uk

GSK says FDA declines to approve higher dose AdvairReuters.uk, UK - Aug 8, 2007L: Quote, Profile , Research) said on Wednesday that US health regulators declined to approve a higher strength version of its inhaled Advair Diskus for the …

Read full story

Comments

Pharma Sector: Few Newsmakers Of The Week - Wyeth, Glaxo, Active … - RTT News

RTT NewsPharma Sector: Few Newsmakers Of The Week - Wyeth, Glaxo, Active …RTT News, NY - Aug 12, 2007British drug giant Glaxosmithkline's hopes to expand labeling for Advair Diskus, which is used to control asthma and chronic obstructive pulmonary disease, …

Read full story

Comments

GSK Supports Emphasis on Asthma Control and Use of Quick … - PR Newswire (press release)

GSK Supports Emphasis on Asthma Control and Use of Quick …PR Newswire (press release), NY - 5 hours agoAdvair Diskus is available by prescription only and is approved for the maintenance treatment of asthma in patients four years of age and older. …

Read full story

Comments

GSK Supports Emphasis on Asthma Control and Use of Quick … - Earthtimes.org

GSK Supports Emphasis on Asthma Control and Use of Quick …Earthtimes.org - 1 hour agoAdvair Diskus is available by prescription only and is approved for the maintenance treatment of asthma in patients four years of age and older. …

Read full story

Comments

Glaxo's Advair Rejected by US FDA for an Added Use (Update1) - Bloomberg

Glaxo's Advair Rejected by US FDA for an Added Use (Update1)Bloomberg - Aug 8, 20078 (Bloomberg) — GlaxoSmithKline Plc failed to win US approval to market the strongest dose of the asthma inhaler Advair Diskus, the company's top-selling …

Read full story

Comments

Glaxo's Advair Rejected by US FDA for an Added Use (Update4) - Bloomberg

Glaxo's Advair Rejected by US FDA for an Added Use (Update4)Bloomberg - Aug 8, 20078 (Bloomberg) — GlaxoSmithKline Plc failed to win US approval of an added use that would have expanded sales of the asthma inhaler Advair Diskus, …

Read full story

Comments

FDA Is Rejecting More New Drugs - Forbes

FDA Is Rejecting More New DrugsForbes, NY - Aug 17, 2007… Sanofi-Aventis' weight-loss drug Zimulti, and even a higher dose of GlaxoSmithKline's Advair Diskus for bronchitis and emphysema symptoms. …Advair Diskus - Google News

Read full story

Comments

FDA more cautious on approving new drugs - Wilkes Barre Times-Leader

FDA more cautious on approving new drugsWilkes Barre Times-Leader, PA - Aug 21, 2007… Sanofi-Aventis’ weight-loss drug Zimulti, and even a higher dose of GlaxoSmithKline’s Advair Diskus for bronchitis and emphysema symptoms. …Advair Diskus - Google News

Read full story

Comments

FDA more cautious on new drug decisions - The Journal News / Lohud.com

FDA more cautious on new drug decisionsThe Journal News / Lohud.com, NY - 15 hours ago… Sanofi-Aventis' weight-loss drug Zimulti, and even a higher dose of GlaxoSmithKline's Advair Diskus for bronchitis and emphysema symptoms. …Advair Diskus - Google News

Read full story

Comments

· « Previous entries